Skip to content

Study · Measured the body's own peptide · 2021

1 result

Activity of Compound Agrimony Enteritis Capsules against invasive candidiasis: Exploring the differences between traditional Chinese medicine prescriptions and its main components in the treatment of diseases.

Li J, Jin ZH, Li JS, Su LY, Wang YX, Zhang Y, Qin DM, Rao GX, Wang RR

Journal of ethnopharmacology18 May 2021Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In mice with invasive candidiasis, FFXHC treatment restored gut microecology and was linked to higher production of the body's own antimicrobial peptide LL‑37 (CRAMP).

    In plain wordsIn mice with a fungal infection, an herbal capsule was linked to more of the mice's own LL‑37-like peptide.

    Peptide
    LL-37
    Outcome
    IncreaseLL-37 (CRAMP) production after FFXHC treatment
    Study

    mousen: not reported in source

    Mouse model of invasive candidiasis
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    which further stimulated the production of the antimicrobial peptide, LL-37, which is required for acquired immunity.
    1 context sentence
    Summary · context
    The mouse model of IC was established and the survival rate, weight change, the number of organ colonies, and immune organ coefficient of the mice

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:57 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.